Other languages Janux Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 20/06/2024 BST			5-day change	1st Jan Change
40.3 ^USD	-0.25%		-4.89%	+275.58%

06-06	Janux Therapeutics Insider Sold Shares Worth $45,043,975, According to a Recent SEC Filing	MT
06-06	Janux Therapeutics Insider Sold Shares Worth $82,125,000, According to a Recent SEC Filing	MT

Janux Therapeutics Insider Sold Shares Worth $45,043,975, According to a Recent SEC Filing	06-06
Janux Therapeutics Insider Sold Shares Worth $82,125,000, According to a Recent SEC Filing	06-06
Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08
Aktien New York: Dow erholt sich vor Start in die Berichtssaison	04-11
Aktien New York: Dow schwächer vor Start in die Berichtssaison	04-11
Aktien New York Ausblick: Vor dem Start in die Berichtssaison stabil erwartet	04-11
Sector Update: Health Care Stocks Slipping Late Afternoon	04-10
Sector Update: Health Care	04-10
Janux Therapeutics Said to be Considering Sale	04-10
Janux Therapeutics Reportedly Weighs Possible Sale	04-09
Janux Therapeutics Q4 Net Loss Narrows, Revenue Decreases	03-08
Janux Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-08
Janux Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-08
Janux Therapeutics Prices $296.5 Million Offering of Common Stock, Pre-Funded Warrants	02-29
Sector Update: Health Care Stocks Ease Late Afternoon	02-27
Sector Update: Health Care	02-27
Aktien New York: Börsen bleiben nahe Rekordhochs	02-27
Top Midday Gainers	02-27
Janux Therapeutics Shares Soar After Wedbush Boosts Price Target Following 'Positive' Data From Two Cancer Studies	02-27
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Key Data for Rate-Cut Hints	02-27

No results for this search